The S&P 500 closed lower on Friday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. 

Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Moderna

• The Trade: Moderna, Inc. (NASDAQ:MRNA) Director Noubar B. Afeyan sold a total of 15,000 shares at an average price of $121.95. The insider received around $1.83 million from selling those shares.
• What’s Happening: Moderna submitted an application to the U.S. Food and Drug Administration for the authorization of its updated vaccine.
• What Moderna Does: Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018.
• Have a look at our premarket coverage here

J. M. Smucker

Amazon.com

Marriott International

Check This Out: Top 5 Industrials Stocks That Should Keep You Up At Night